SCHEMBL4519503

SCHEMBL4519503

CCOC(=O)c1ccn2c(C(=O)c3ccc(NC(=O)C(F)(F)F)c(OC)c3)nc(NC(=O)c3cccc(OCCCCCCCCOc4cccc(C(=O)Nc5nc(C(=O)c6ccc(NC(=O)C(F)(F)F)c(OC)c6)n6ccc(C(=O)OCC)cc56)c4)c3)c2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCC9 O60706 1/20 0.36
▸ ABCC8 Q09428 1/20 0.36
▸ KCNJ11 Q14654 1/20 0.36
▸ KCNJ8 Q15842 1/20 0.36
▸ TP53 P04637 2/20 0.36
▸ POLB P06746 1/20 0.36
▸ MAPT P10636 4/20 0.35
▸ SMPD1 P17405 3/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ TSHR P16473 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ BLM P54132 1/20 0.34
▸ NR1H4 Q96RI1 2/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ L3MBTL1 Q9Y468 2/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4519504 0.98 NR1H4 (0.37) ABCC9ABCC8KCNJ11KCNJ8TP53
SCHEMBL1573133 0.93 ABCC9 (0.40) ABCC9ABCC8KCNJ11KCNJ8MAPT
SCHEMBL4497581 0.81 ABCC9 (0.41) ABCC9ABCC8KCNJ11KCNJ8TP53
SCHEMBL4505532 0.81 ALOX15 (0.41) ABCC9ABCC8KCNJ11KCNJ8TP53
SCHEMBL4502430 0.79 NR1H4 (0.42) SMPD1KMT2ANR1H4
SCHEMBL1573154 0.72 ABCC9 (0.45) ABCC9ABCC8KCNJ11KCNJ8MEN1
SCHEMBL4514601 0.70 SMPD1 (0.38) TP53POLBSMPD1MEN1KMT2A
SCHEMBL4504643 0.67 NR1H4 (0.40) SMPD1MEN1KMT2ANR1H4
SCHEMBL1932569 0.66 KMT2A (0.46) TP53MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL4420899 0.64 ABCC9 (0.47) ABCC9ABCC8KCNJ11KCNJ8TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9120819-B2 FGF-receptor agonist dimeric compounds SANOFI (FR) 2015-09-01 — — US disclosed
US-20090069368-A1 FGF-RECEPTOR AGONIST DIMERIC COMPOUNDS SANOFI-AVENTIS (FR) 2009-03-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069368-A1 FGF-RECEPTOR AGONIST DIMERIC COMPOUNDS FGF2, FGFR1, FGF1 ABCC9 3947/4885ABCC8 3724/4885KCNJ11 4771/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback